GK Trademark

Trademark Overview


On Wednesday, September 11, 2019, a trademark application was filed for GK with the United States Patent and Trademark Office. The USPTO has given the GK trademark a serial number of 79272513. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by CHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.). The GK trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical preparations for human use to minimize heterogeneity caused by endogenous enzymes in the course of cell culture for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, certain conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, namely, pharmaceutical antibodies or its fragments or its derivatives; cells and genes that produce antibodies, ...

Granting of licenses to others for the use of industrial property rights and copyright

Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals

General Information


Serial Number79272513
Word MarkGK
Filing DateWednesday, September 11, 2019
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6422155
Registration DateTuesday, July 20, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized Greek letter "Delta" and the stylized Latin letters "GK".
Goods and ServicesPharmaceutical preparations for human use to minimize heterogeneity caused by endogenous enzymes in the course of cell culture for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, certain conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, namely, pharmaceutical antibodies or its fragments or its derivatives; cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Transliteration StatementThe transliteration of the non-Latin characters in the mark is: "delta".
Goods and ServicesGranting of licenses to others for the use of industrial property rights and copyright
Goods and ServicesPharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 25, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 25, 2019
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameCHUGAI SEIYAKU KABUSHIKI KAISHA (ChugaiPharmaceutical Co., Ltd.)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Saturday, January 28, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, January 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 1, 2021GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, December 1, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, October 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Monday, May 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Sunday, May 2, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 21, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 21, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 14, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 29, 2021EXAMINER'S AMENDMENT ENTERED
Monday, March 29, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 29, 2021EXAMINERS AMENDMENT E-MAILED
Monday, March 29, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 10, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 10, 2021EX PARTE APPEAL-INSTITUTED
Wednesday, February 10, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 10, 2021EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, August 12, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 12, 2020FINAL REFUSAL E-MAILED
Wednesday, August 12, 2020FINAL REFUSAL WRITTEN
Thursday, July 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 19, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 15, 2020REFUSAL PROCESSED BY IB
Friday, January 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 24, 2020REFUSAL PROCESSED BY MPU
Friday, December 13, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 12, 2019NON-FINAL ACTION WRITTEN
Wednesday, December 11, 2019ASSIGNED TO EXAMINER
Friday, November 29, 2019APPLICATION FILING RECEIPT MAILED
Monday, November 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB